Skip to content
10-Q

Quarterly Report

RESMED INC RMD RSMDF

0000943819-24-000027

← back to feed
Filed
Oct 25, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Oct 21, 2024 146.8M sh
Short Term Debt Q1 2025 · Sep 30, 2024 $9.9M
Short Term Debt Q1 2025 · Jun 30, 2024 $9.9M
Cash And Equivalents Q1 2025 · Sep 30, 2024 $426.36M
Cash And Equivalents Q1 2025 · Jun 30, 2024 $238.36M
Current Liabilities Q1 2025 · Sep 30, 2024 $904.08M
Current Liabilities Q1 2025 · Jun 30, 2024 $910.66M
Total Liabilities Q1 2025 · Sep 30, 2024 $2.03B
Total Liabilities Q1 2025 · Jun 30, 2024 $2.01B
Current Assets Q1 2025 · Sep 30, 2024 $2.64B
Current Assets Q1 2025 · Jun 30, 2024 $2.36B
Total Assets Q1 2025 · Sep 30, 2024 $7.22B
Total Assets Q1 2025 · Jun 30, 2024 $6.87B
Shares Diluted Q1 2025 · Sep 30, 2023 147.49M sh
Stock Repurchased Q1 2025 · Sep 30, 2023 $0
Dividends Paid Q1 2025 · Sep 30, 2023 $70.6M
Capex Q1 2025 · Sep 30, 2023 $30.04M
Operating Cash Flow Q1 2025 · Sep 30, 2023 $286.28M
Stockholders Equity Q1 2025 · Sep 30, 2023 $4.25B
Stockholders Equity Q1 2025 · Jun 30, 2023 $4.13B
Eps Diluted Q1 2025 · Sep 30, 2023 $1.49
Eps Basic Q1 2025 · Sep 30, 2023 $1.49
Sga Expense Q1 2025 · Sep 30, 2023 $222.87M
Rd Expense Q1 2025 · Sep 30, 2023 $75.71M
Net Income Q1 2025 · Sep 30, 2023 $219.42M
Operating Income Q1 2025 · Sep 30, 2023 $289M
Gross Profit Q1 2025 · Sep 30, 2023 $600.06M
Cost Of Revenue Q1 2025 · Sep 30, 2023 $502.26M
Revenue Q1 2025 · Sep 30, 2023 $1.1B